Grants per year
Personal profile
Research Interests
Dr. Moreira’s clinical practice is focused on hematopoietic stem cell transplantation for hematologic and solid malignancies. His academic interests include protocol development for novel therapeutic agents for stem cell transplant conditioning regimens, management of graft vs. host disease, and lymphoid malignancies. He is also interested in conducting research that addresses cancer disparities amongst underserved communities, both locally and globally.
Dr. Jonathan Moreira is an Assistant Professor of Medicine in the Department of Medicine, Division of Hematology/Oncology at Northwestern University’s Feinberg School of Medicine. After receiving dual bachelor degrees at the University of Illinois at Urbana-Champaign, he returned to his native Chicago, where he received a medical degree from Loyola University Chicago’s Stritch School of Medicine. He then went on to complete a residency in Internal Medicine at Mayo Clinic in Rochester, Minnesota. He returned to Chicago to complete a fellowship in Hematology/Oncology at Northwestern University’s Feinberg School of Medicine.
Hematopoietic Stem Cell Transplantation for benign and malignant hematologic conditions, both autologous and allogeneic. Hematopoietic Stem Cell Transplantation for solid tumors.
Certifications and Licenses
| Medical Oncology and Hematology | |
| Internal Medicine |
Training Experience
| 2012 | Residency, Mayo Medical School |
| 2016 | Fellowship, Northwestern University, McGaw Medical Center |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Medicine, Loyola University/Stritch School of Medicine
… → 2009
Research interests keywords
- Biologic Therapies
- Blood Cancer (leukemia and lymphomas)
- Chemotherapy
- Chronic Lymphocytic Leukemia
- Cutaneous T-Cell Lymphoma
- Health Disparities
- Hematology
- Stem Cells
- Transplantation
Fingerprint
Dive into the research topics where Jonathan Moreira is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Mosaic: RCT of a Digital Health Intervention Delivering Peer Support Narratives and Psychoeducation to English- and Spanish-Speaking Stem Cell Transplant Recipients
Rini, C. (PD/PI), Moreira, J. (Co-Investigator) & Yanez, B. R. (Co-Investigator)
8/1/24 → 7/31/29
Project: Research project
-
Prot #EQ-100-02: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Itolizumab in Combination with Corticosteroids for the Initial Treatment of Acute Graft Versus Host Disease
Moreira, J. (PD/PI)
Equillium, Inc., Medpace Clinical Research LLC
7/17/24 → 7/17/27
Project: Research project
-
Prot #EFC17757: A Randomized, Double-Blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of Belumosudil in Combination with Corticosteroids Versus Placebo in Combination with Corticosteroids in Participants at Least 12 Years of Age with Newl
Moreira, J. (PD/PI)
ICON Clinical Research, LLC, Sanofi US Services Inc.
4/26/24 → 4/26/27
Project: Research project
-
Prot #AVM-003-HC: Phase 3 Multicenter, Double-Blind, Placebo-Controlled Trial of Viralym-M (ALVR-105) for the Treatment of Patients With Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplant
Moreira, J. (PD/PI)
Medpace Clinical Research LLC, AlloVir, Inc
10/28/20 → 3/10/26
Project: Research project
-
1/3: The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)
Feinglass, J. M. (PD/PI), Feinglass, J. M. (PD/PI), Simon, M. A. (PD/PI), Simon, M. A. (PD/PI), Murphy, A. B. (Co-Investigator), Murphy, A. B. (Co-Investigator), Sun, Z. (Co-Investigator), Sun, Z. (Co-Investigator), Holmes, K. (Other), Holmes, K. (Other), Kocherginsky, M. (Other), McKoy, J. M. (Other), McKoy, J. M. (Other), Moreira, J. (Other) & Moreira, J. (Other)
9/19/20 → 8/31/25
Project: Research project
-
Evaluating Socioeconomic, Racial, and Ethnic Disparities in Survival Among Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplants
Garcia, L., Feinglass, J., Marfatia, H., Adekola, K. & Moreira, J., Jun 2024, In: Journal of Racial and Ethnic Health Disparities. 11, 3, p. 1330-1338 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy
Karmali, R., Machhi, R., Epperla, N., Shouse, G., Romancik, J., Moyo, T. K., Kenkre, V., Ollila, T. A., Fitzgerald, L., Hess, B., David, K., Roy, I., Zurko, J., Chowdhury, S. M., Annunzio, K., Ferdman, R., Bhansali, R. S., Harris, E. I., Liu, J. & Nizamuddin, I. & 11 others, , May 28 2024, In: Blood Advances. 8, 10, p. 2592-2599 8 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy
Melody, M., Epperla, N., Shouse, G., Romancik, J., Allen, P., Moyo, T. K., Kenkre, V., Ollila, T., Fitzgerald, L., Hess, B., David, K., Herr, M. M., Odetola, O., Lin, A., Moreira, J., Ma, S., Winter, J. N., Roy, I., Stephens, D. & Danilov, A. & 6 others, , May 28 2024, In: Blood Advances. 8, 10, p. 2327-2331 5 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Hematopoietic Cell Transplantation, Version 3.2022 Featured Updates to the NCCN Guidelines
Saad, A., Loren, A., Bolaños-Meade, J., Chen, G., Couriel, D., Di Stasi, A., El-Jawahri, A., Elmariah, H., Farag, S., Gundabolu, K., Gutman, J., Ho, V., Hoeg, R., Horwitz, M., Hsu, J., Kassim, A., Dabaja, M. K., Magenau, J., Martin, T. & Mielcarek, M. & 13 others, , Feb 2023, In: JNCCN Journal of the National Comprehensive Cancer Network. 21, 2, p. 108-115 8 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma
Ruan, J., Zain, J., Palmer, B., Jovanovic, B., Mi, X., Swaroop, A., Winter, J. N., Gordon, L. I., Karmali, R., Moreira, J., Petrich, A. M. & Pro, B., Oct 10 2023, In: Blood Advances. 7, 19, p. 5771-5779 9 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Scopus citations